A randomized phase II study of radiation induced immune boost in operable non-small cell lung cancer (RadImmune trial)

BACKGROUND: Lung cancer is the leading cause of cancer deaths worldwide. Surgery, radiotherapy at conventional and high dose and chemotherapy are the mainstay for lung cancer treatment. Insufficient migration and activation of tumour specific effector T cells seem to be important reasons for inadequ...

Descripción completa

Detalles Bibliográficos
Autores principales: Safi, Seyer, Beckhove, Philipp, Warth, Arne, Benner, Axel, Roeder, Falk, Rieken, Stefan, Debus, Juergen, Dienemann, Hendrik, Hoffmann, Hans, Huber, Peter E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4684916/
https://www.ncbi.nlm.nih.gov/pubmed/26686362
http://dx.doi.org/10.1186/s12885-015-2006-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4684916/
https://www.ncbi.nlm.nih.gov/pubmed/26686362
http://dx.doi.org/10.1186/s12885-015-2006-2

Ejemplares similares